Users Coming Off Weight-Loss Jabs Put On Pounds at a Quadrupled Rate Than People Using Diet and Exercise

A recent study suggests that patients who come off popular weight-loss injections like semaglutide or tirzepatide tend to recover lost weight at a significantly accelerated pace than those who stop traditional diet and exercise regimens.

Research printed in a leading medical journal shows that while overweight people frequently drop substantial amounts of their body weight while on the medication, the mass is regained at an estimated rate of 0.8 kg per month after stopping.

"Individuals using these treatments should be aware of the risk of fast rebound weight gain when the medication is stopped," stated researcher Dr. Susan Jebb.

That rate of regain means a reversion to pre-treatment weight within about one and a half years.

Weighing Treatments

The research, which examined dozens of studies involving thousands of patients, contrasted the outcomes of GLP-1 agonists with conventional dieting.

The team point out that people who shed pounds through diet and exercise generally have a less rapid creep back—approximately 100 grams monthly—once they finish.

Explaining the Quick Rebound

Nutrition scientists propose the mechanism of the injections explains the heightened weight return.

GLP-1 drugs mimic a body's own chemical called GLP-1, which moderates appetite.

"Long-term administration of GLP-1 levels far above than the body's typical production might result in the body to generate a reduced amount of its endogenous hormone, and may also lessen responsiveness to its actions," explained Dr. Adam Collins, a nutrition expert.

"Discontinuation of this GLP-1 'fix' leads to appetite is uncontrolled, making excessive eating a significant risk."

An Ongoing Condition?

Medical guidelines suggest the jabs for people with weight-linked health risks, alongside prescribed diet and exercise modifications.

A number of clinicians contend that, considering the likelihood of weight regain, the therapy is often life-long.

This opinion is supported by drug manufacturers, who note that the results "underscore the persistent nature of obesity," comparing it to managing conditions like hypertension.

User Accounts

Individuals who have discontinued the medication explain a powerful resurgence of appetite.

"It was like a trigger that goes on and I was suddenly ravenous," recalled an individual.

This difficulty is worsened if patients have not adopted permanent lifestyle or habit modifications during therapy.

Significant Use

Figures show that a significant number of adults in the UK have tried these injections in the past year, with desire continuing to grow.

• Adoption is higher among females compared to men.
• The middle-aged demographic shows the highest level of interest.
• A large proportion access the medications through private prescriptions rather than public health services.

In conclusion, clinicians stress that while the jabs are powerful tools for shedding pounds, they are not a permanent cure and maintained weight loss relies on integrated lifestyle changes.